Malignant Paraganglioma With Calvarial Metastases Presenting With Recurrent Catecholamine-Induced Cardiomyopathy

Authors: Beatrice A. Brumley, MD, Run Yu, MD, PhD, Shadfar Bahri, MD, Jane Rhyu, MD

Source: AACE Clinical Case Reports, Vol 11, Iss 1, Pp 24-28 (2025)

Subject Terms: metastatic pheochromocytoma/paraganglioma (PCC/PGL), calvarial metastases, catecholamine-induced cardiomyopathy, peptide receptor radionuclide therapy (PRRT), Diseases of the endocrine glands. Clinical endocrinology, RC648-665

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S237606052400107X; https://doaj.org/toc/2376-0605

Access URL: https://doaj.org/article/8b46f2c16d4649c69af8a5b15b876b88

The Safety and Efficacy of Peptide Receptor Radionuclide Therapy for Gastro-Entero-Pancreatic Neuroendocrine Tumors: A Single Center Experience

Authors: Leandra Piscopo, Emilia Zampella, Fabio Volpe, Valeria Gaudieri, Carmela Nappi, Erica Di Donna, Stefania Clemente, Antonio Varallo, Mariano Scaglione, Alberto Cuocolo, Michele Klain

Source: Current Oncology, Vol 31, Iss 9, Pp 5617-5629 (2024)

Subject Terms: gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs), peptide receptor radionuclide therapy (PRRT), [177Lu]Lu-DOTA-TATE, multidisciplinary team, dosimetry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.mdpi.com/1718-7729/31/9/416; https://doaj.org/toc/1198-0052; https://doaj.org/toc/1718-7729

Access URL: https://doaj.org/article/a2dee3d0e61b43c9b6b706b9d0bab36d

The South Australian 177Lu-DOTATATE peptide receptor radionuclide therapy service: an 11-year review of toxicity, health-related quality of life, and survival

Authors: L.M. Altus, J.C. Forster, J. Mercurio, M. Kitchener, N. Corsini, M. Nenke, T. Price, D. Patel, R. Chew, D. Moffat, S. Unger, G. Cehic

Source: ESMO Gastrointestinal Oncology, Vol 8, Iss , Pp 100146- (2025)

Subject Terms: peptide receptor radionuclide therapy (PRRT), neuroendocrine neoplasms/tumours (NENs/NETs), [177Lu]-DOTA-octreotate (177Lu-DOTATATE), health-related quality of life (hr-QoL), radioligand therapy (RLT), theranostics, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2949819825000159; https://doaj.org/toc/2949-8198

Access URL: https://doaj.org/article/10569671e771489d83603434fc4f89ac

'Cold' Somatostatin Analogs in Neuroendocrine Neoplasms: Decoding Mechanisms, Overcoming Resistance, and Shaping the Future of Therapy

Authors: Sara Massironi, Manuela Albertelli, Iderina Hasballa, Piero Paravani, Diego Ferone, Antongiulio Faggiano, Silvio Danese

Source: Cells, Vol 14, Iss 4, p 245 (2025)

Subject Terms: somatostatin analogs (SSAs), somatostatin receptors (SSTRs), neuroendocrine neoplasms (NENs), peptide receptor radionuclide therapy (PRRT), high-dose SSA therapy, Cytology, QH573-671

File Description: electronic resource

Relation: https://www.mdpi.com/2073-4409/14/4/245; https://doaj.org/toc/2073-4409

Access URL: https://doaj.org/article/2386a4a11c6040b0930982d809a5168f

Complete loss of E-cadherin expression in a rare case of metastatic malignant meningioma: a case report

Authors: Dominik Lisowski, Philipp E. Hartrampf, Natalie Hasenauer, Vera Nickl, Camelia-Maria Monoranu, Jörg Tamihardja

Source: BMC Neurology, Vol 23, Iss 1, Pp 1-7 (2023)

Subject Terms: Beta-catenin, E-cadherin, Meningioma, Peptide receptor radionuclide therapy (PRRT), Radiotherapy, Neurology. Diseases of the nervous system, RC346-429

File Description: electronic resource

Relation: https://doaj.org/toc/1471-2377

Access URL: https://doaj.org/article/120176e112dc4afea2e498b122ca8868

GRPR-targeting radiotheranostics for breast cancer management

Authors: Alice D’Onofrio, Swantje Engelbrecht, Tilman Läppchen, Axel Rominger, Eleni Gourni

Source: Frontiers in Medicine, Vol 10 (2023)

Subject Terms: gastrin-releasing peptide receptor (GRPR), Bombesin, breast cancer, molecular imaging, peptide receptor radionuclide therapy (PRRT), Medicine (General), R5-920

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fmed.2023.1250799/full; https://doaj.org/toc/2296-858X

Access URL: https://doaj.org/article/d800166837b94aada0fe363fec5401d8

Peptide Receptor Radionuclide Therapy Using 177Lu-DOTATATE in Advanced Neuroendocrine Tumors (NETs) in a Limited-Resource Environment

Authors: Mohammadreza Kalantarhormozi, Samaneh Hassanzadeh, Seyed Javad Rekabpour, Mohammad Reza Ravanbod, Esmail Jafari, AbdulLatif Amini, Habibollah Dadgar, Mehdi Mahmoudpour, Iraj Nabipour, Narges Jokar, Majid Assadi

Source: World Journal of Nuclear Medicine, Vol 21, Iss 03, Pp 215-221 (2022)

Subject Terms: neuroendocrine tumors (nets), peptide receptor radionuclide therapy (prrt), 177lu-dotatate, 68ga-dotatate pet-ct, 99mtc-octreotide scintigraphy, Medical physics. Medical radiology. Nuclear medicine, R895-920

File Description: electronic resource

Relation: https://doaj.org/toc/1450-1147; https://doaj.org/toc/1607-3312

Access URL: https://doaj.org/article/433e8af8a60c41938c115dc1be534d36

Impressive Response to TANDEM Peptide Receptor Radionuclide Therapy with 177Lu/225AcDOTA-LM3 Somatostatin Receptor Antagonist in a Patient with Therapy-Refractory, Rapidly Progressive Neuroendocrine Neoplasm of the Pancreas

Authors: Elisabetta Perrone, Kriti Ghai, Aleksandr Eismant, Mikkel Andreassen, Seppo W. Langer, Ulrich Knigge, Andreas Kjaer, Richard P. Baum

Source: Diagnostics, Vol 14, Iss 9, p 907 (2024)

Subject Terms: pancreas, neuroendocrine neoplasm, Peptide Receptor Radionuclide Therapy (PRRT), Lutetium-177, Actinium-225, TANDEM-PRRT, Medicine (General), R5-920

File Description: electronic resource

Relation: https://www.mdpi.com/2075-4418/14/9/907; https://doaj.org/toc/2075-4418

Access URL: https://doaj.org/article/954bf3749ed14039a4459a0950bb60ba

Long-term prognostic factors for PRRT in neuroendocrine tumors

Authors: Nils Florian Trautwein, Johannes Schwenck, Johann Jacoby, Gerald Reischl, Francesco Fiz, Lars Zender, Helmut Dittmann, Martina Hinterleitner, Christian la Fougère

Source: Frontiers in Medicine, Vol 10 (2023)

Subject Terms: neuroendocrine tumor (NET), 177Lu, DOTA-TATE, peptide receptor radionuclide therapy (PRRT), Ga-HA-DOTATATE, molecular tumor volume, Medicine (General), R5-920

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fmed.2023.1169970/full; https://doaj.org/toc/2296-858X

Access URL: https://doaj.org/article/608e55b2203e4f3e9540bddda76b7f37

Cutaneous Management after Extravasation of High-Concentrated Amino Acid Solution Administered for Renal Protection in PRRT

Authors: Chaninart Sakulpisuti, Wichana Chamroonrat, Supatporn Tepmongkol

Source: Tomography, Vol 8, Iss 1, Pp 356-363 (2022)

Subject Terms: peptide receptor radionuclide therapy (PRRT), extravasation, amino acid, cutaneous lesion, Computer applications to medicine. Medical informatics, R858-859.7

File Description: electronic resource

Relation: https://www.mdpi.com/2379-139X/8/1/29; https://doaj.org/toc/2379-1381; https://doaj.org/toc/2379-139X

Access URL: https://doaj.org/article/a380124d10c94d9b82468ee630d4e674

Bioprosthetic valve monitoring in patients with carcinoid heart disease

Authors: Kevin A. Honan, Saamir Hassan, Anita Deswal, Joerg Herrmann, Juhee Song, Dominique Monlezun, Daniel Halperin, Armeen Mahvash, Arvind Dasari, Efstratios Koutroumpakis, Mehmet Akay, Dinu-Valentin Balanescu, Ismael Salas de Armas, Manish Patel, Sriram Nathan, Biswajit Kar, Konstantinos Marmagkiolis, Juan Lopez-Mattei, Jay Patel, Igor Gregoric, James Yao, Cezar A. Iliescu

Source: Frontiers in Cardiovascular Medicine, Vol 9 (2023)

Subject Terms: cardio-oncology, carcinoid heart disease, telotristat ethyl, peptide receptor radionuclide therapy (PRRT), pulmonary valve, tricuspid valve repair, Diseases of the circulatory (Cardiovascular) system, RC666-701

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fcvm.2022.1072890/full; https://doaj.org/toc/2297-055X

Access URL: https://doaj.org/article/7e6653e1a92a45efa6c1581f13d9dc27

Alpha-peptide receptor radionuclide therapy using actinium-225 labeled somatostatin receptor agonists and antagonists

Authors: Mengqi Shi, Vivianne Jakobsson, Lukas Greifenstein, Pek-Lan Khong, Xiaoyuan Chen, Richard P. Baum, Jingjing Zhang

Source: Frontiers in Medicine, Vol 9 (2022)

Subject Terms: actinium-225, neuroendocrine tumor, peptide receptor radionuclide therapy (PRRT), targeted α-particle therapy, SSTR, SSTR antagonist, Medicine (General), R5-920

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fmed.2022.1034315/full; https://doaj.org/toc/2296-858X

Access URL: https://doaj.org/article/2bbd26c1e218460f83eba0de87ee8bb0

The evolution of PRRT for the treatment of neuroendocrine tumors; What comes next?

Authors: Philip E. Harris, Konstantin Zhernosekov

Source: Frontiers in Endocrinology, Vol 13 (2022)

Subject Terms: peptide receptor radionuclide therapy (PRRT), targeted radionuclide therapy (TRT), neuroendocrine tumors (NETs), Lutetium-177, Ga-68 PET, dosimetry, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fendo.2022.941832/full; https://doaj.org/toc/1664-2392

Access URL: https://doaj.org/article/2498b7ea891248fd94530d74a2fdd8a0

Initial clinical evaluation of indigenous 90Y-DOTATATE in sequential duo-PRRT approach (177Lu-DOTATATE and 90Y-DOTATATE) in neuroendocrine tumors with large bulky disease: Observation on tolerability,90Y-DOTATATE post- PRRT imaging characteristics (bremsstrahlung and PETCT) and early adverse effects

Authors: Rahul Parghane, Arpit Mitra, Trupti Bannore, Sutapa Rakshit, Sharmila Banerjee, Sandip Basu

Source: World Journal of Nuclear Medicine, Vol 20, Iss 01, Pp 73-81 (2021)

Subject Terms: 177lu-dotatate, 68ga-dotatate pet-ct, 90y-dotatate, duo-prrt, peptide receptor radionuclide therapy (prrt), tandem prrt, Medical physics. Medical radiology. Nuclear medicine, R895-920

File Description: electronic resource

Relation: https://doaj.org/toc/1450-1147; https://doaj.org/toc/1607-3312

Access URL: https://doaj.org/article/046990d0e908446188f0ac070dc10a8a

Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms? – A preclinical assessment in vitro and in vivo

Authors: Franziska Briest, Eva J. Koziolek, Jakob Albrecht, Fränze Schmidt, Monique R. Bernsen, Joost Haeck, Anja A. Kühl, Dagmar Sedding, Teresa Hartung, Samantha Exner, Martina Welzel, Christian Fischer, Carsten Grötzinger, Winfried Brenner, Richard P. Baum, Patricia Grabowski

Source: Neoplasia: An International Journal for Oncology Research, Vol 23, Iss 1, Pp 80-98 (2021)

Subject Terms: Bortezomib, Neuroendocrine tumors, Peptide receptor radionuclide therapy (PRRT), DNA repair, Combination therapy, Proteasome inhibition, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S147655862030172X; https://doaj.org/toc/1476-5586

Access URL: https://doaj.org/article/ae7137f1c25a44b7a686f53aa5278365

Extravasation of [177Lu]Lu-DOTATOC: case report and discussion

Authors: Anne Kirstine Arveschoug, Anne Charlotte Bekker, Peter Iversen, Henrik Bluhme, Gerda Elisabeth Villadsen, Peter Frøhlich Staanum

Source: EJNMMI Research, Vol 10, Iss 1, Pp 1-7 (2020)

Subject Terms: Extravasation, Peptide-receptor radionuclide therapy (PRRT), Kidney dosimetry, [177Lu]Lu-DOTATOC, Medical physics. Medical radiology. Nuclear medicine, R895-920

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s13550-020-00658-6; https://doaj.org/toc/2191-219X

Access URL: https://doaj.org/article/089bbd5a3f1e420fa30d3e6d72a631e9

Lutathera® Orphans: State of the Art and Future Application of Radioligand Therapy with 177Lu-DOTATATE

Authors: Luca Urso, Alberto Nieri, Licia Uccelli, Angelo Castello, Paolo Artioli, Corrado Cittanti, Maria Cristina Marzola, Luigia Florimonte, Massimo Castellani, Sergio Bissoli, Francesca Porto, Alessandra Boschi, Laura Evangelista, Mirco Bartolomei

Source: Pharmaceutics, Vol 15, Iss 4, p 1110 (2023)

Subject Terms: Lutathera®, 177Lu-DOTATATE, thera(g)nostics, radioligand therapy (RLT), peptide receptor radionuclide therapy (PRRT), somatostatin receptor (SSTR), Pharmacy and materia medica, RS1-441

File Description: electronic resource

Relation: https://www.mdpi.com/1999-4923/15/4/1110; https://doaj.org/toc/1999-4923

Access URL: https://doaj.org/article/378435a6c4914f93a56c7b538e6a105f

Dosimetry after peptide receptor radionuclide therapy: impact of reduced number of post-treatment studies on absorbed dose calculation and on patient management

Authors: Alexandre Chicheportiche, Simona Ben-Haim, Simona Grozinsky-Glasberg, Kira Oleinikov, Amichay Meirovitz, David J. Gross, Jeremy Godefroy

Source: EJNMMI Physics, Vol 7, Iss 1, Pp 1-15 (2020)

Subject Terms: Peptide receptor radionuclide therapy (PRRT), [177Lu]-DOTA-TATE, Dosimetry, SPECT/CT, Medical physics. Medical radiology. Nuclear medicine, R895-920

File Description: electronic resource

Relation: https://doaj.org/toc/2197-7364

Access URL: https://doaj.org/article/a401101d6a12450499a616365693d97d

Peptide receptor radionuclide therapy in the management of neuroendocrine tumors (Neoplasms)*: Fundamentals and salient clinical practice points for medical oncologists

Authors: Sandip Basu, Rahul Parghane, Rohit Ranade, Pradeep Thapa, Anant Ramaswamy, Vikas Ostwal, Bhawna Sirohi, Dipanjan Panda, Shailesh V Shrikhande

Source: Indian Journal of Medical and Paediatric Oncology, Vol 40, Iss 2, Pp 165-171 (2019)

Subject Terms: neuroendocrine tumor, neuroendocrine neoplasm, peptide receptor radionuclide therapy (prrt), somatostatin receptor imaging, 68ga-dotatate pet-ct, 99mtc-hynic-toc spect, fdg-pet/ct, 177lu-dotatate, 90y-dotatoc, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.ijmpo.org/article.asp?issn=0971-5851;year=2019;volume=40;issue=2;spage=165;epage=171;aulast=Basu; https://doaj.org/toc/0971-5851; https://doaj.org/toc/0975-2129

Access URL: https://doaj.org/article/1489d67f74354814af0eced1201a92c0

Comparison of Choi, RECIST and Somatostatin Receptor PET/CT Based Criteria for the Evaluation of Response and Response Prediction to PRRT

Authors: Kevin Zwirtz, Juliane Hardt, Güliz Acker, Alexander D. J. Baur, Marianne Pavel, Kai Huang, Winfried Brenner, Vikas Prasad

Source: Pharmaceutics, Vol 14, Iss 6, p 1278 (2022)

Subject Terms: peptide receptor radionuclide therapy (PRRT), Ga-68 DOTATOC, Ga-68 DOTATATE, PET/CT, RECIST, Choi, Pharmacy and materia medica, RS1-441

File Description: electronic resource

Relation: https://www.mdpi.com/1999-4923/14/6/1278; https://doaj.org/toc/1999-4923

Access URL: https://doaj.org/article/d00fb7990fbe4f97aa54a3e3af881fc1